Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - OxySure Therapeutics, Inc. | f8k030314ex99i_oxysuresys.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report March 3, 2014
|
OxySure Systems, Inc.
|
|
(Exact name of registrant as specified in its charter)
|
|
Delaware
|
000-54137
|
71-0960725
|
||
|
(State or other jurisdiction of
incorporation
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
10880 John W. Elliott Drive, Suite 600,
Frisco, TX
|
75033
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(972) 294-6450
|
|
Registrant's telephone number, including area code
|
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02. Results of Operations and Financial Condition.
On March 3, 2014, OxySure Systems, Inc. (the “Company”) issued a press release in which the Company discloses its cash position as at December 31, 2013 to be in excess of $657,000. A copy of the press release is furnished herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
Exhibit 99.1. Press release dated March 3, 2014.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: March 3, 2014
|
||
|
OXYSURE SYSTEMS, INC.,
|
||
|
a Delaware corporation
|
||
|
By:
|
/s/ Julian T. Ross
|
|
|
Julian T. Ross
|
||
|
ITS:
|
Chief Executive Officer, President
|
|
|
Chief Financial Officer, and Secretary
|
||
3